Literature DB >> 33219450

IgA vasculitis nephritis in children and adults: one or different entities?

Licia Peruzzi1,2, Rosanna Coppo3.   

Abstract

The clinical features of the kidney involvement in immunoglobulin A (IgA) vasculitis (IgAVN) differ in children and adults for both clinical presentation and progression. IgAVN in children has mostly a self-limiting course and favorable resolution, while in adults the kidney involvement is frequently severe with unfavorable outcome. However, a subset of children is at risk of progression within the pediatric age or decades later in adulthood, particularly when the diagnosis and a prompt intervention are delayed. Factors predicting progression and outcome in the whole spectrum of age have been investigated in recent research, as well as the relationship between IgAVN and primary IgAN, which share the same pathology features, in the light of peculiar clinical differences and progression tendencies, and hence need for selective treatments. The search for a personalized treatment in children with IgAV and in different ages of life should rely on the identification of different risks for progression. This review will focus on recent studies which contribute to improve our knowledge in this still largely unclear area.
© 2020. IPNA.

Entities:  

Keywords:  Adults; Children; Henoch-Schonlein purpura nephritis; IgA vasculitis; Progression; Risk factors; Treatment

Mesh:

Year:  2020        PMID: 33219450     DOI: 10.1007/s00467-020-04818-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  75 in total

1.  Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins.

Authors:  Janet M M Gardner-Medwin; Pavla Dolezalova; Carole Cummins; Taunton R Southwood
Journal:  Lancet       Date:  2002-10-19       Impact factor: 79.321

2.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

Review 3.  IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects.

Authors:  Alexandra Audemard-Verger; Evangeline Pillebout; Loïc Guillevin; Eric Thervet; Benjamin Terrier
Journal:  Autoimmun Rev       Date:  2015-02-14       Impact factor: 9.754

4.  Avoiding "Rash" Conclusions: Challenge of IgA Vasculitis in Adults.

Authors:  S Hu; A Birg; M Hovaida; M W Gavin; D McCarthy
Journal:  Dig Dis Sci       Date:  2017-04       Impact factor: 3.199

Review 5.  Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy.

Authors:  Jean-Claude Davin
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-10       Impact factor: 8.237

6.  Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.

Authors:  Lorraine Harper; Krishnarajah Nirantharakumar; Alexander Tracy; Anuradhaa Subramanian; Nicola J Adderley; Paul Cockwell; Charles Ferro; Simon Ball
Journal:  Ann Rheum Dis       Date:  2018-11-28       Impact factor: 19.103

7.  Aberrant right subclavian artery--esophageal fistula: a cause of overwhelming upper gastrointestinal hemorrhage.

Authors:  R I Belkin; F S Keller; E C Everts; J Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

Review 8.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

9.  Henoch schonlein purpura--a 5-year review and proposed pathway.

Authors:  Louise Watson; Amanda R W Richardson; Richard C L Holt; Caroline A Jones; Michael W Beresford
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.

Authors:  David T Selewski; Josephine M Ambruzs; Gerald B Appel; Andrew S Bomback; Raed Bou Matar; Yi Cai; Daniel C Cattran; Aftab S Chishti; Vivette D D'Agati; Cynthia J D'Alessandri-Silva; Rasheed A Gbadegesin; Jonathan J Hogan; Sandra Iragorri; J Charles Jennette; Bruce A Julian; Myda Khalid; Richard A Lafayette; Helen Liapis; Francesca Lugani; Sarah A Mansfield; Sherene Mason; Patrick H Nachman; Cynthia C Nast; Carla M Nester; Damien G Noone; Jan Novak; Michelle M O'Shaughnessy; Heather N Reich; Michelle N Rheault; Dana V Rizk; Manish K Saha; Neil S Sanghani; C John Sperati; Rajasree Sreedharan; Tarak Srivastava; Agnieszka Swiatecka-Urban; Katherine Twombley; Tetyana L Vasylyeva; Donald J Weaver; Hong Yin; Jarcy Zee; Ronald J Falk; Ali G Gharavi; Brenda W Gillespie; Debbie S Gipson; Larry A Greenbaum; Lawrence B Holzman; Matthias Kretzler; Bruce M Robinson; William E Smoyer; Michael Flessner; Lisa M Guay-Woodford; Krzysztof Kiryluk
Journal:  Kidney Int Rep       Date:  2018-08-03
View more
  2 in total

1.  IgA vasculitis in children.

Authors:  Maria Goretti Moreira Guimarães Penido; Lilian Monteiro Pereira Palma
Journal:  J Bras Nefrol       Date:  2022-02-11

2.  A simple nomogram for assessing the risk of IgA vasculitis nephritis in IgA vasculitis Asian pediatric patients.

Authors:  Yuna Bi; Wei Quan; Wei Hao; Rui Sun; Liwen Li; Chunping Jiang; Lingling Tian; Lin Liu; Jie Liu; Xiaozhong Li; Tao Li
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.